Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses. Kieseier BC, Stüve O, Dehmel T, Goebels N, Leussink VI, Mausberg AK, Ringelstein M, Turowski B, Aktas O, Antoch G, et al. Arch Neurol. 2012 Dec 24:1-4. PMID: 23266885. Abstract CommentRecommendBookmarkWatch